Sunshine Biopharma Inc.
SBFM | NASDAQ
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
+$0.06 (+6.24%)
Pre-market:
Sep 22, 2026, 4:16 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.85 | -0.41 | -1.55 | -0.36 | -0.60 | -0.49 |
PEG Ratio | 0.01 | 0 | 0.02 | 0.01 | 0 | 0.01 |
PS Ratio | 0.14 | 0.06 | 0.27 | 2.24 | 33.52 | 19.13 |
PB Ratio | 0.22 | 0.09 | 0.31 | 0.45 | 36.18 | -1.43 |
P/FCF Ratio | -0.93 | -0.14 | -0.69 | -1.75 | -4.19 | -2.07 |
P/OCF Ratio | -0.96 | -0.17 | -0.75 | -1.85 | -4.19 | -2.08 |
OCF/S Ratio | -14.68 | -35.93 | -36.42 | -120.77 | -800.75 | -920.46 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.03 | 0.04 | 8.98 | -2 |
Quick Ratio | 2.08 | 2.33 | 3.45 | 3.47 | 22.91 | 0.95 |
Current Ratio | 4.17 | 4.11 | 4.48 | 3.94 | 24.07 | 0.98 |
Asset Turnover | 1.21 | 1.14 | 0.88 | 0.15 | 0.10 | 0.07 |
Interest Coverage | n/a | -662.43 | -34.85 | -220.09 | -7.42 | -3.43 |
Return on Equity | -25.94% | -21.85% | -21.25% | -123.66% | -5.88K% | 291.58% |
Return on Assets | -19.87% | -16.80% | -16.48% | -90.52% | -564.55% | -266.30% |
Return on Invested Capital | -18.78% | -22.73% | -21.84% | -38.15% | -115.56% | -60.20% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 32.84% | 30.59% | 34.61% | 39.04% | 48.42% | 63.80% |
Net Profit Margin | -16.46% | -14.72% | -18.70% | -615.44% | -5.44K% | -3.9K% |
Pretax Profit Margin | -16.40% | -15.40% | -17.06% | -610.07% | -5.44K% | -3.9K% |
Operating Profit Margin | -12.34% | -16.67% | -19.86% | -199.60% | -1.07K% | -807.83% |
FCF Margin | -15.16% | -42.59% | -39.69% | -127.79% | -800.75% | -922.13% |
EBITDA Margin | -15.48% | -14.73% | -15.87% | -608.58% | -5.29K% | -3.64K% |
Add to Watchlist
Select watchlists to add or remove SBFM